Galderma Group AG/ADR

Galderma Group AG

Drug Manufacturers - Specialty & Generic Healthcare Zug, Switzerland GDERF (PNK)

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes ACTINICA, Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, Mirvaso, NEMLUVIO, Relfydess, Benzac, Loceryl, and TRI-LUMA in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.

Stock Performance (90 Days)

Data through Feb 13, 2026
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Other Drug Manufacturers - Specialty & Generic Companies

View All →

Frequently Asked Questions

Has Galderma Group AG/ADR had layoffs?
No layoff events have been recorded for Galderma Group AG/ADR in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
What industry is Galderma Group AG/ADR in?
Galderma Group AG/ADR operates in the Drug Manufacturers - Specialty & Generic industry, within the Healthcare sector.
Is Galderma Group AG/ADR a publicly traded company?
Yes, Galderma Group AG/ADR is publicly traded under the ticker symbol GDERF on the PNK. The company has a market capitalization of approximately $49.28 billion.
Where is Galderma Group AG/ADR headquartered?
Galderma Group AG/ADR is headquartered in Zug, Switzerland at Zählerweg 10, Switzerland.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.